Publication | Closed Access

Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance

Gatekeeper MutationCell SignalingReceptor Tyrosine KinaseFibroblast Growth FactorCell BiologyMedicineRadiation OncologyCancer ResearchTumor MicroenvironmentTumor BiologyCancer GrowthTumour Cell Responses